Chromogranin A, LC/MS/MS

The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.


*Important Information on Lab Test Processing Times: Ulta Lab Tests is committed to informing you about the processing times for your lab tests processed through Quest Diagnostics. Please note that the estimated processing time for each test, indicated in business days, is based on data from the past 30 days across the 13 Quest Diagnostics laboratories for each test. These estimates are intended to serve as a guide and are not guarantees. Factors such as laboratory workload, weather conditions, holidays, and the need for additional testing or maintenance can influence actual processing times. We aim to offer estimates to help you plan accordingly. Please understand that these times may vary, and processing times are not guaranteed. Thank you for choosing Ulta Lab Tests for your laboratory needs.

The Chromogranin A, LC/MS/MS test contains 1 test with 1 biomarker.

Brief Description: The Chromogranin A (CgA) test measures the level of chromogranin A in the blood. Chromogranin A is a protein found in neuroendocrine cells, which are distributed throughout the body and play a role in the nervous and endocrine systems. Elevated levels of chromogranin A can indicate the presence of a neuroendocrine tumor.

Collection Method: Blood Draw

Specimen Type: Serum

Test Preparation: No preparation required

When and Why a Chromogranin A Test May be Ordered

A health care provider may order a Chromogranin A test when a person has symptoms suggestive of a neuroendocrine tumor. These symptoms can vary widely based on the tumor's location and may include:

  • Flushing of the skin
  • Diarrhea
  • Wheezing or difficulty breathing
  • Unexplained weight loss
  • Gastric ulcers

Additionally, the test may be ordered periodically to monitor the progress of a known neuroendocrine tumor or to evaluate the effectiveness of treatment for such tumors.

What the Chromogranin A Test Checks For

The Chromogranin A test checks for elevated levels of the chromogranin A protein in the blood. Elevated levels can be indicative of a neuroendocrine tumor, but they can also be raised in other conditions or due to certain medications.

Other Lab Tests Ordered Alongside the Chromogranin A Test

When a Chromogranin A test is ordered, it's often part of a broader evaluation of suspected neuroendocrine tumors or related hormonal disorders. Here are some tests commonly ordered alongside it:

  1. 5-Hydroxyindoleacetic Acid (5-HIAA) Urine Test:

    • Purpose: To measure the level of 5-HIAA, a breakdown product of serotonin, in the urine.
    • Why Is It Ordered: Many carcinoid tumors produce serotonin, which is metabolized into 5-HIAA. Elevated levels can be indicative of a carcinoid tumor.
  2. Serotonin Serum Test:

    • Purpose: To measure the level of serotonin in the blood.
    • Why Is It Ordered: To assess serotonin production, often elevated in patients with carcinoid tumors.
  3. Pancreatic Polypeptide (PP) Test:

    • Purpose: To measure the level of pancreatic polypeptide, produced by certain types of pancreatic neuroendocrine tumors.
    • Why Is It Ordered: To help in diagnosing pancreatic neuroendocrine tumors.
  4. Gastrin Test:

    • Purpose: To measure the level of gastrin in the blood.
    • Why Is It Ordered: Elevated gastrin levels can be indicative of gastrin-producing tumors (gastrinomas), part of the Zollinger-Ellison syndrome.
  5. Insulin and C-Peptide Tests:

    • Purpose: To measure levels of insulin and C-peptide, which are co-secreted by the pancreas.
    • Why Is It Ordered: To diagnose insulinomas, a type of pancreatic neuroendocrine tumor that produces excessive insulin.
  6. ACTH and Cortisol Tests:

    • Purpose: To measure levels of ACTH and cortisol.
    • Why Is It Ordered: Some neuroendocrine tumors, particularly those arising from the lung, can ectopically produce ACTH, leading to increased cortisol production and Cushing's syndrome.
  7. Complete Blood Count (CBC) and Comprehensive Metabolic Panel (CMP):

    • Purpose: To evaluate overall health status, including kidney and liver function.
    • Why Is It Ordered: To assess general health and organ function, which can be affected by neuroendocrine tumors.

These tests, when ordered alongside a Chromogranin A test, provide a comprehensive evaluation of neuroendocrine function and help in diagnosing and monitoring neuroendocrine tumors. They are crucial for identifying the type and extent of neuroendocrine tumors, understanding their impact on hormonal balance, and guiding appropriate treatment. The specific combination of tests will depend on the individual’s symptoms, clinical presentation, and the suspected type of neuroendocrine tumor.

Conditions or Diseases that Require the Chromogranin A Test

The primary condition for which the Chromogranin A test is ordered is to detect and monitor neuroendocrine tumors. These tumors can be benign or malignant and can originate in various body parts, such as the lungs, pancreas, or intestines. Notable types include carcinoid tumors and pheochromocytomas.

Usage of Chromogranin A Test Results by Health Care Providers

The results of the Chromogranin A test can be used in the following ways:

  • Diagnosis: Elevated levels can point towards the presence of a neuroendocrine tumor.
  • Treatment Monitoring: Levels of chromogranin A can be tracked over time to assess the effectiveness of treatments or to detect recurrence.
  • Prognosis: Extremely high levels might suggest a more aggressive or widespread tumor.

However, chromogranin A levels can also be elevated due to other conditions, including liver or kidney disease, or by certain medications such as proton pump inhibitors. Therefore, results should always be interpreted in the context of a broader clinical picture and additional testing.

Most Common Questions About the Chromogranin A test:

Purpose and Indications for the Test

Why is the Chromogranin A test performed?

The Chromogranin A test is often performed to diagnose, monitor, and track the progression of neuroendocrine tumors (NETs). Chromogranin A (CgA) is a protein secreted by neuroendocrine cells, and elevated levels can indicate the presence or growth of NETs.

How does the Chromogranin A test differ from other tests for neuroendocrine tumors?

The Chromogranin A test focuses on detecting the presence of the Chromogranin A protein, a specific marker for NETs. While there are other markers and tests for neuroendocrine tumors, the Chromogranin A test is commonly used due to its sensitivity for certain types of NETs. However, it's essential to consider it alongside other clinical findings and diagnostic tools for a comprehensive diagnosis.

Interpreting the Results

What do elevated levels of Chromogranin A indicate?

Elevated levels of Chromogranin A typically suggest the presence or progression of neuroendocrine tumors. However, elevated levels can also occur in other conditions, such as chronic atrophic gastritis, kidney failure, or being on certain medications like proton pump inhibitors.

Is a single elevated Chromogranin A test result enough for a NET diagnosis?

No, a single elevated result isn't conclusive for a NET diagnosis. It's crucial to corroborate the Chromogranin A test results with other diagnostic tools, clinical findings, and possibly repeated tests over time. This ensures an accurate diagnosis and avoids misinterpretation.

Implications and Management

If my Chromogranin A levels are high, what are the next steps in diagnosis and management?

If your Chromogranin A levels are high, your healthcare provider will likely recommend further diagnostic tests such as imaging studies, other blood tests, or biopsies to pinpoint the tumor's location and type. Once diagnosed, the treatment options might include surgery, targeted therapies, radiation, or other treatments specific to NETs.

How frequently should someone with a known NET undergo the Chromogranin A test?

The frequency varies depending on the individual's case, the type of NET, and the treatment plan. However, regular monitoring using the Chromogranin A test can help track the tumor's progression or regression and assess the effectiveness of ongoing treatments.

Test Mechanisms and Specifics

Why might Chromogranin A levels fluctuate in someone without a neuroendocrine tumor?

Apart from NETs, other factors can influence Chromogranin A levels. These include certain medications, renal impairment, liver diseases, inflammatory conditions, and even some dietary factors. It's crucial to consider these factors when interpreting the results.

How does the Chromogranin A test differentiate between different types of neuroendocrine tumors?

The Chromogranin A test, in itself, doesn't differentiate between different types of NETs. It merely indicates the presence of elevated CgA levels. Differentiating between NET types typically requires other diagnostic tools like imaging, histological examinations, and other biochemical tests.

Additional Information

Is the Chromogranin A test useful for all types of neuroendocrine tumors?

No, while the Chromogranin A test is helpful for many NETs, its sensitivity varies. For instance, it's more sensitive for detecting certain types of NETs like gastrinomas and carcinoids than others. Therefore, it's crucial to use the test in conjunction with other diagnostic tools for a comprehensive evaluation.

Can other conditions or factors falsely elevate Chromogranin A levels?

Yes, several conditions and factors can falsely elevate Chromogranin A levels. Common culprits include the use of proton pump inhibitors (a type of acid-reducing medication), kidney dysfunction, and certain inflammatory conditions. It's vital for clinicians to be aware of these factors when interpreting results.

We advise having your results reviewed by a licensed medical healthcare professional for proper interpretation of your results.

Customer Reviews